Original language | English |
---|---|
Pages (from-to) | 515-524 |
Number of pages | 10 |
Journal | Mucosal Immunology |
Volume | 15 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Mucosal Immunology, Vol. 15, No. 3, 03.2022, p. 515-524.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
AU - Bohnacker, Sina
AU - Hartung, Franziska
AU - Henkel, Fiona
AU - Quaranta, Alessandro
AU - Kolmert, Johan
AU - Priller, Alina
AU - Ud-Dean, Minhaz
AU - Giglberger, Johanna
AU - Kugler, Luisa M.
AU - Pechtold, Lisa
AU - Yazici, Sarah
AU - Lechner, Antonie
AU - Erber, Johanna
AU - Protzer, Ulrike
AU - Lingor, Paul
AU - Knolle, Percy
AU - Chaker, Adam M.
AU - Schmidt-Weber, Carsten B.
AU - Wheelock, Craig E.
AU - Esser-von Bieren, Julia
N1 - Funding Information: This study was supported by the German Research Foundation (DFG) (FOR2599, ES 471/3-1; ES 471/2-3), a Helmholtz Young Investigator grant (VH-NG-1331) to J.E.v.B. and grants by the Swedish Heart Lung Foundation HLF 20210519, HLF 20200693 to C.E.W., the German University Medicine network NUM via project B-FAST, the For-COVID consortium funded by the state of Bavaria and the Project “Virological and immunological determinants of COVID-19 pathogenesis – lessons to get prepared for future pandemics (KA1-Co-02 “COVIPA”)”, a grant from the Helmholtz Association’s Initiative and Networking Fund to UP and PK. C.S.-W. receives grant support by the German Center for Lung Research (DZL; 82DZL00302). Open Access funding enabled and organized by Projekt DEAL. Funding Information: We would like to thank members of the SeCoMRI study group, Sonja Schindela and staff of the histology laboratory of the Dermatology Department, Klinikum rechts der Isar and of the Helmholtz Center Munich Genomics platform for technical support. Funding Information: C. B. S.-W. received grant support from Allergopharma, PLS Design, as well as Zeller AG; and received speaker honoraria from Allergopharma. U. Protzer is co-funder, board member and share holder of SCG Cell Therapy Inc. and serves as ad hoc advisor for Sanofi-Pasteur, BioNTech, Janssen and Swedish Orphan Biovitrum concerning COVID-19. The rest of the authors declare that they have no relevant conflicts of interest related to this work.
PY - 2022/3
Y1 - 2022/3
UR - http://www.scopus.com/inward/record.url?scp=85126194658&partnerID=8YFLogxK
U2 - 10.1038/s41385-021-00482-8
DO - 10.1038/s41385-021-00482-8
M3 - Article
C2 - 35288643
AN - SCOPUS:85126194658
SN - 1933-0219
VL - 15
SP - 515
EP - 524
JO - Mucosal Immunology
JF - Mucosal Immunology
IS - 3
ER -